Cargando…

Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine

Detalles Bibliográficos
Autores principales:	Mehta, Sangeeta, Granton, John, Gordon, Anthony C., Cook, Deborah J., Lapinsky, Stephen, Newton, Gary, Bandayrel, Kris, Little, Anjuli, Siau, Chuin, Ayers, Dieter, Singer, Joel, Lee, Terry C. K., Walley, Keith R., Storms, Michelle, Cooper, D. James, Holmes, Cheryl L., Hebert, Paul, Presneill, Jeffrey, Russell, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415714/ https://www.ncbi.nlm.nih.gov/pubmed/28468661 http://dx.doi.org/10.1186/s13054-017-1680-7

Ejemplares similares

Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
por: Mehta, Sangeeta, et al.
Publicado: (2013)

Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009)

Vasopressin versus norepinephrine in septic shock: a propensity score matched efficiency retrospective cohort study in the VASST coordinating center hospital
por: Russell, James A., et al.
Publicado: (2018)

Vasopressin versus norepinephrine for the management of septic shock in cancer patients
por: Zambolim, C, et al.
Publicado: (2014)

Hemodynamic effects of association of vasopressin and norepinephrine in patients with septic shock
por: Fathallah, B, et al.
Publicado: (2008)

Clinical trials comparing norepinephrine with vasopressin in patients with septic shock: a meta-analysis
por: Zhou, Fei-Hu, et al.
Publicado: (2014)

Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock
por: Russell, James A., et al.
Publicado: (2019)

Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology
por: Holmes, Cheryl L, et al.
Publicado: (2003)

Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology
por: Holmes, Cheryl L, et al.
Publicado: (2004)

Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: A systematic review and meta-analysis
por: Sedhai, Yub Raj, et al.
Publicado: (2022)

Norepinephrine/vasopressin: Lack of efficacy: case report
Publicado: (2020)

Norepinephrine/vasopressin: Lack of efficacy: case report
Publicado: (2020)

Norepinephrine/vasopressin: Lack of efficacy: case report
Publicado: (2022)

Norepinephrine/vasopressin: Lack of drug effect: case report
Publicado: (2020)

Norepinephrine/phenylephrine/vasopressin: Lack of efficacy: case report
Publicado: (2020)

Epinephrine/norepinephrine/vasopressin: Lack of efficacy: case report
Publicado: (2021)

A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*
por: He, Xinrong, et al.
Publicado: (2016)

Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis
por: Song, Jae-Uk, et al.
Publicado: (2019)

Vasopressin in Conjunction With Norepinephrine in Septic Shock: A Retrospective Cohort Study From a Low Middle-Income Country
por: Raza, Hussain Ahmed, et al.
Publicado: (2020)

Arteriolar vasoconstrictive response: comparing the effects of arginine vasopressin and norepinephrine
por: Friesenecker, Barbara E, et al.
Publicado: (2006)

Arginine vasopressin versus norepinephrine: will the stronger one win the race?
por: Ertmer, Christian, et al.
Publicado: (2006)

Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics
por: Fage, Nicolas, et al.
Publicado: (2023)

Norepinephrine infusion in septic shock
por: Haranath, P. S. R. K.
Publicado: (2008)

Bench-to-bedside review: Vasopressin in the management of septic shock
por: Russell, James A
Publicado: (2011)

Potential for overuse of corticosteroids and vasopressin in septic shock
por: Hsu, Joe L, et al.
Publicado: (2012)

Norepinephrine/phenylephrine/vasopressin: Takotsubo cardiomyopathy and lack of efficacy: case report
Publicado: (2021)

Renal effect of dopamine, norepinephrine, epinephrine, or norepinephrine–dobutamine in septic shock
por: Qiu, HB, et al.
Publicado: (2002)

Vasopressin versus norepinephrine infusion in patients with vasoplegic shock after cardiac surgery
por: Hajjar, L, et al.
Publicado: (2009)

Distributive Shock in Erythrodermic Psoriasis Treated With Norepinephrine and Vasopressin: A Case Report
por: Karimi, Mehrdad, et al.
Publicado: (2023)

Selepressin, a novel selective vasopressin V(1A) agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
por: Russell, James A., et al.
Publicado: (2017)

Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: Few Concerns
por: Khera, Daisy, et al.
Publicado: (2023)

Norepinephrine in Septic Shock: A Mixed Blessing
por: Uhel, Fabrice, et al.
Publicado: (2020)

Use of vasopressin in the treatment of refractory septic shock
por: Kny, Katiuce Tomazi, et al.
Publicado: (2018)

Norepinephrine combined with phenylephrine versus norepinephrine in patients with septic shock: a retrospective cohort study
por: He, Dan, et al.
Publicado: (2023)

Comparative study of dopamine and norepinephrine in the management of septic shock
por: Agrawal, Avinash, et al.
Publicado: (2011)

Effect of norepinephrine dosage on mortality in patients with septic shock
por: Yamamura, Hitoshi, et al.
Publicado: (2018)

Alternatives to norepinephrine in septic shock: Which agents and when?
por: Jozwiak, Mathieu
Publicado: (2022)

Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study
por: Sahoo, Pallavi, et al.
Publicado: (2022)

Clinical review: Vasopressin and terlipressin in septic shock patients
por: Delmas, Anne, et al.
Publicado: (2005)

Dear vasopressin, where is your place in septic shock?
por: Duenser, Martin W, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_78roh319md1ecd4g47cp5cjsbn